AU2001259626A1 - Indole derivatives and their use as 15-lipoxygenase inhibitors - Google Patents

Indole derivatives and their use as 15-lipoxygenase inhibitors

Info

Publication number
AU2001259626A1
AU2001259626A1 AU2001259626A AU5962601A AU2001259626A1 AU 2001259626 A1 AU2001259626 A1 AU 2001259626A1 AU 2001259626 A AU2001259626 A AU 2001259626A AU 5962601 A AU5962601 A AU 5962601A AU 2001259626 A1 AU2001259626 A1 AU 2001259626A1
Authority
AU
Australia
Prior art keywords
indole derivatives
lipoxygenase inhibitors
lipoxygenase
inhibitors
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001259626A
Other languages
English (en)
Inventor
David Thomas Connor
William Howard Roark
Roderick Joseph Sorenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU2001259626A1 publication Critical patent/AU2001259626A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AU2001259626A 2000-06-14 2001-05-08 Indole derivatives and their use as 15-lipoxygenase inhibitors Abandoned AU2001259626A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21148900P 2000-06-14 2000-06-14
US60/211,489 2000-06-14
US60211489 2000-06-14
PCT/US2001/014798 WO2001096299A2 (en) 2000-06-14 2001-05-08 Indole derivatives and their use as 15-lipoxygenase inhibitors

Publications (1)

Publication Number Publication Date
AU2001259626A1 true AU2001259626A1 (en) 2001-12-24

Family

ID=22787118

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001259626A Abandoned AU2001259626A1 (en) 2000-06-14 2001-05-08 Indole derivatives and their use as 15-lipoxygenase inhibitors

Country Status (8)

Country Link
US (1) US6858739B2 (ja)
EP (1) EP1294686A2 (ja)
JP (1) JP2004503535A (ja)
AU (1) AU2001259626A1 (ja)
BR (1) BR0111564A (ja)
CA (1) CA2411116A1 (ja)
MX (1) MXPA02011396A (ja)
WO (1) WO2001096299A2 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001261269A1 (en) * 2000-06-14 2001-12-24 Warner Lambert Company 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
DK1452528T3 (da) 2001-11-16 2008-11-10 Nippon Chemiphar Co Xanthinoxidaserinhibitorer
JP2006521345A (ja) * 2003-03-28 2006-09-21 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ニコチン性アセチルコリン受容体の正のアロステリック調節剤
MXPA06000538A (es) * 2003-07-15 2006-03-30 Smithkline Beecham Corp Compuestos novedosos.
US20090247766A1 (en) * 2008-03-27 2009-10-01 University Of Southern California Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof
US20230117592A1 (en) * 2019-12-23 2023-04-20 Sri International Lipoxygenase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6966696A (en) * 1995-10-05 1997-04-28 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
US6001866A (en) * 1995-10-05 1999-12-14 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis

Also Published As

Publication number Publication date
JP2004503535A (ja) 2004-02-05
WO2001096299A3 (en) 2002-07-18
WO2001096299A2 (en) 2001-12-20
US20040038943A1 (en) 2004-02-26
CA2411116A1 (en) 2001-12-20
US6858739B2 (en) 2005-02-22
BR0111564A (pt) 2003-04-29
EP1294686A2 (en) 2003-03-26
MXPA02011396A (es) 2003-04-25

Similar Documents

Publication Publication Date Title
AU2001240542A1 (en) Heterocyclic compounds and their use as parp inhibitors
AU2003287160A1 (en) Substituted indoles and their use as hcv inhibitors
SI1686119T1 (sl) Derivati pirimidin-5-ona kot inhibitorji ldl-pla2
AU2001274009A1 (en) Substituted indoles as parp inhibitors
AU2002228316A1 (en) Carbazole derivatives and their uses as heparanase inhibitors
HK1057214A1 (en) New mandelic acid derivatives and their use as throbin inhibitors
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
PL356427A1 (en) Indol-3-yl derivatives and their use as integrin inhibitors
AU2001231664A1 (en) Indol-3-yl derivatives
AU2001233837A1 (en) Benzthiazoles as tnf and pde-iv inhibitors
AU2001289758A1 (en) Novel indole derivatives and their use as medicaments
PL354979A1 (en) Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors
IL143987A0 (en) New amidinobenzylamine derivatives and their use as thrombin inhibitors
AU2001244596A1 (en) Indolylpyrrole derivatives and cell death inhibitors
AU4501199A (en) 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
AU2002216650A1 (en) Triazine derivatives as lpaat-b inhibitors and uses thereof
AU3235100A (en) Prothease inhibitors
AU2002239263A1 (en) Tetracyclic carbazole derivates and their use as spla2 inhibitors
AU2001259626A1 (en) Indole derivatives and their use as 15-lipoxygenase inhibitors
AU2001232809A1 (en) Gyrase inhibitors and uses thereof
AU2001266124A1 (en) 2-aminothiazoline derivatives and their use as no-synthase inhibitors
AU2001277561A1 (en) Biphenyl derivatives and the use thereof as integrin inhibitors
AU2002230056A1 (en) Indole derivatives and their uses as heparanase inhibitors
AU1039801A (en) Compounds and their use as cysteine protease inhibitors
AU2003218715A1 (en) Azepane derivatives and their use as atk1 inhibitors